These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2914601)

  • 21. Biologic and clinical implications of marrow culture studies in the myelodysplastic syndromes.
    Greenberg PL
    Semin Hematol; 1996 Apr; 33(2):163-75. PubMed ID: 8722686
    [No Abstract]   [Full Text] [Related]  

  • 22. Bone marrow blasts level predicts prognosis in patients with refractory cytopenia with multilineage dysplasia.
    Wang H; Wang XQ; Xu XP; Lin GW
    Eur J Haematol; 2009 Dec; 83(6):550-8. PubMed ID: 19737310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexistence of Sézary syndrome and dysmyelopoiesis with an excess of myeloblasts.
    Rostoker G; Raphael M; Boisnick S; Charron D
    J Am Acad Dermatol; 1986 Dec; 15(6):1296-8. PubMed ID: 3805369
    [No Abstract]   [Full Text] [Related]  

  • 24. Preleukemia: bone marrow histopathology in myelodysplasia and preleukemic syndrome.
    Georgii A; Vykoupil KF; Buhr T
    Recent Results Cancer Res; 1988; 106():159-71. PubMed ID: 3368642
    [No Abstract]   [Full Text] [Related]  

  • 25. Clonal remissions in acute myeloid leukaemia are commonly associated with features of trilineage myelodysplasia during remission.
    Jowitt SN; Liu Yin JA; Saunders MJ; Lucas GS
    Br J Haematol; 1993 Dec; 85(4):698-705. PubMed ID: 7918032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Myelodysplasia" from copper deficiency.
    Siddiqui S; Ramlal R
    Blood; 2019 Feb; 133(8):883. PubMed ID: 30792227
    [No Abstract]   [Full Text] [Related]  

  • 27. [CME myelodysplasia - a frequent hematologic neoplasia in the elderly].
    Schleiffenbaum BE
    Praxis (Bern 1994); 2014 May; 103(11):617-27. PubMed ID: 24846886
    [No Abstract]   [Full Text] [Related]  

  • 28. Diagnostic approach to the myelodysplastic syndromes.
    Cazzola M; Ponchio L; Rosti V; Farina G; Pedrotti C; Bergamaschi G
    Leukemia; 1992 Nov; 6 Suppl 4():19-22. PubMed ID: 1434825
    [No Abstract]   [Full Text] [Related]  

  • 29. [New cognition of diagnosis and classification in myelodysplastic syndromes].
    Pu Q
    Zhonghua Nei Ke Za Zhi; 1999 Jun; 38(6):365-7. PubMed ID: 12795293
    [No Abstract]   [Full Text] [Related]  

  • 30. [Myelodysplastic syndromes].
    Raza A; Vadhan-Raj S; Chávez-Sánchez G
    Rev Invest Clin; 1997 May; 49 Suppl 1():15-21. PubMed ID: 9380984
    [No Abstract]   [Full Text] [Related]  

  • 31. Lifetime treatment of mice with azidothymidine (AZT) produces myelodysplasia.
    Inoue T; Cronkite EP; Hirabayashi Y; Bullis JE; Mitsui H; Umemura T
    Leukemia; 1997 Apr; 11 Suppl 3():123-7. PubMed ID: 9209318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Functional characteristics of hematopoietic and stromal cells in various forms of myelodysplastic syndrome].
    Gerasimova LP; Manakova TE; Tsvetaeva NV; Lukina EA; Kozlovskaia AS
    Biull Eksp Biol Med; 1999 Jan; 127(1):14-8. PubMed ID: 10189996
    [No Abstract]   [Full Text] [Related]  

  • 33. [Myelodysplastic syndrome: a review].
    Creutzig U; Hoelzer D
    Klin Padiatr; 1987; 199(3):169-72. PubMed ID: 3626418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Myelodysplastic syndromes in children].
    Samochatova EV
    Gematol Transfuziol; 1992 Feb; 37(2):5-9. PubMed ID: 1426909
    [No Abstract]   [Full Text] [Related]  

  • 35. Kinetic analysis of cloning patterns by human marrow cells in leukemia.
    Galbraith PR; Cooke LJ; Galbraith MA
    Clin Invest Med; 1985; 8(3):227-31. PubMed ID: 3862490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myelodysplasia: clinical and morphological aspects and treatment.
    Geary CG
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():138-40. PubMed ID: 2653491
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects on bone marrow during stimulation of hematopoietic stem cells with recombinant human interleukin-3].
    Falk S; Seipelt G; Ganser A; Hoelzer D; Stutte HJ; Hübner K
    Verh Dtsch Ges Pathol; 1990; 74():111-5. PubMed ID: 1708566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS.
    Amigo ML; del Cañizo MC; Rios A; Garcia MA; Caballero MD; Martin A; Bermejo N; Vilches P; San Miguel JF
    Bone Marrow Transplant; 1999 May; 23(10):997-1002. PubMed ID: 10373064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myelodysplasia with fibrosis: a distinct entity?
    Steensma DP; Hanson CA; Letendre L; Tefferi A
    Leuk Res; 2001 Oct; 25(10):829-38. PubMed ID: 11532514
    [No Abstract]   [Full Text] [Related]  

  • 40. Allogeneic peripheral blood stem cell transplant for myelodysplasia after chemotherapy for post-transplant lymphoma in a cardiac transplant recipient at 10 years.
    Lister J; Simpson JK; deMagalhaes-Silverman MM; Rybka WB; Donnenberg AD; Myers DJ; Ball ED
    Bone Marrow Transplant; 1997 May; 19(9):943-5. PubMed ID: 9156271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.